NBRV
Dimensional Fund Advisors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-33,723
| Closed | -$40K | – | 3609 |
|
2021
Q3 | $40K | Hold |
33,723
| – | – | ﹤0.01% | 3483 |
|
2021
Q2 | $46K | Sell |
33,723
-1,579
| -4% | -$2.15K | ﹤0.01% | 3441 |
|
2021
Q1 | $59K | Buy |
35,302
+14,190
| +67% | +$23.7K | ﹤0.01% | 3386 |
|
2020
Q4 | $51K | Sell |
21,112
-227,776
| -92% | -$550K | ﹤0.01% | 3316 |
|
2020
Q3 | $133K | Sell |
248,888
-183,444
| -42% | -$98K | ﹤0.01% | 3243 |
|
2020
Q2 | $292K | Sell |
432,332
-217,780
| -33% | -$147K | ﹤0.01% | 3166 |
|
2020
Q1 | $374K | Sell |
650,112
-144,869
| -18% | -$83.3K | ﹤0.01% | 3107 |
|
2019
Q4 | $1.05M | Sell |
794,981
-167,448
| -17% | -$221K | ﹤0.01% | 2995 |
|
2019
Q3 | $1.93M | Sell |
962,429
-4,400
| -0.5% | -$8.8K | ﹤0.01% | 2862 |
|
2019
Q2 | $2.35M | Buy |
966,829
+207,584
| +27% | +$504K | ﹤0.01% | 2860 |
|
2019
Q1 | $1.85M | Buy |
759,245
+158,852
| +26% | +$388K | ﹤0.01% | 2911 |
|
2018
Q4 | $877K | Hold |
600,393
| – | – | ﹤0.01% | 3041 |
|
2018
Q3 | $1.62M | Buy |
600,393
+256,332
| +75% | +$692K | ﹤0.01% | 2972 |
|
2018
Q2 | $1.2M | Buy |
344,061
+232,196
| +208% | +$808K | ﹤0.01% | 2993 |
|
2018
Q1 | $563K | Buy |
111,865
+70,917
| +173% | +$357K | ﹤0.01% | 3087 |
|
2017
Q4 | $245K | Buy |
+40,948
| New | +$245K | ﹤0.01% | 3192 |
|